University of California Davis (UCDAVIS)

Raman ChemLighter: Fiber optic Raman probe imaging in combination with augmented chemical reality (2019) Yang W, Mondol AS, Stiebing C, Marcu L, Popp J, Schie IW Journal article OBETICHOLIC ACID TREATMENT IS ASSOCIATED WITH IMPROVED COLLAGEN MORPHOMETRY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (2019) Kremer A, Bowlus CL, Bedossa P, Pares A, Forman LM, Drenth JPH, Ryder S, et al. Conference contribution THE STRESS AND ADVERSITY INVENTORY FOR ADULTS (ADULT STRAIN) IN GERMAN: AN INITIAL VALIDATION (2019) Sturmbauer S, Shields GS, Hetzel EL, Rohleder N, Slavich GM Conference contribution Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial (2019) Dalekos G, Invernizzi P, Nevens F, Hans VV, Zigmond E, Andrade RJ, Ben Ari Z, et al. Conference contribution Long-term obeticholic acid treatment is associated with improvements in collagen morphometry in patients with primary biliary cholangitis (2019) Kremer A, Bowlus C, Bedossa P, Pares A, Forman L, Drenth JP, Ryder S, et al. Conference contribution Global Consensus on Definition, Classification, Diagnosis, and Staging of Limbal Stem Cell Deficiency (2019) Deng SX, Borderie V, Chan CC, Dana R, Figueiredo FC, Gomes JAP, Pellegrini G, et al. Journal article Three years of obeticholic Acid (OCA) therapy results in histological improvements in patients with primary biliary cholangitis: further analysis of the POISE Biopsy substudy (2019) Bowlus CL, Pockros PJ, Kremer A, Pares A, Forman LM, Drenth JPH, Ryder S, et al. Conference contribution An international intercomparison of stable carbon isotope composition measurements of dissolved inorganic carbon in seawater (2019) Cheng L, Normandeau C, Bowden R, Doucett R, Gallagher B, Gillikin DP, Kumamoto Y, et al. Journal article, Original article Pressure-induced chemical reordering in supercooled polyionic sulfophosphate liquids (2018) Rodrigues BP, Sen S, Wondraczek L Journal article Treatment efficacyand safety of seladelpar, a selective peroxisome proliferator-activated receptor delta agonist, in primary biliary cholangitis patients: 12-and 26-week analysis from an ongoing international, randomized, dose raging phase 2 study (2018) Hirschfield G, Boudes P, Bowlus C, Gitlin N, Michael G, Harrison S, Gordon SC, et al. Conference contribution